Clinical Trial Update: Efficacy and Safety Study of Isuzinaxib in Subjects With DKD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of Isuzinaxib in subjects with Diabetic kidney disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Isuzinaxib (Isuzinaxib)

Snippet

Sponsor: Aptabio Therapeutics, Inc. | Conditions: Diabetic Kidney Disease (DKD) | Phase 2 | Status: RECRUITING